Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Walther

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
The Urologic Clinics of North America|February 1, 1991
Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulationR V LaRocca, M R Cooper, M Uhrich, et al.
The Journal of Urology|March 1, 1995
Parenchymal sparing surgery in patients with hereditary renal cell carcinomaM M Walther, P L Choyke, G Weiss, et al.
The Journal of Urology|March 1, 1994
Hereditary papillary renal cell carcinomaB Zbar, K Tory, M Merino, et al.
The Journal of Urology|July 1, 1993
Intraoperative ultrasound in the evaluation of tumor involvement of the inferior vena cavaJ P Long, P L Choyke, T A Shawker, et al.
Radiology|June 1, 1991
von Hippel-Lindau disease: inadequacy of angiography for identification of renal cancersD L Miller, P L Choyke, M M Walther, et al.
The Journal of Urology|February 25, 1998
Serum interleukin-6 levels in metastatic renal cell carcinoma before treatment with interleukin-2 correlates with paraneoplastic syndromes but not patient survivalM M Walther, B Johnson, D Culley, et al.
World Journal of Urology|January 1, 1996
Isolated perfusion of the kidney with tumor necrosis factor for localized renal-cell carcinomaM M Walther, S B Jennings, P L Choyke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancerC Myers, M Cooper, C Stein, et al.
Journal of the National Cancer Institute|April 20, 2001
Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytomaK Pacak, T Fojo, D S Goldstein, et al.
Urology|September 1, 1993
Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinomaM M Walther, R B Alexander, G H Weiss, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
The Urologic Clinics of North America|February 1, 1991
Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulationR V LaRocca, M R Cooper, M Uhrich, et al.
The Journal of Urology|March 1, 1995
Parenchymal sparing surgery in patients with hereditary renal cell carcinomaM M Walther, P L Choyke, G Weiss, et al.
The Journal of Urology|March 1, 1994
Hereditary papillary renal cell carcinomaB Zbar, K Tory, M Merino, et al.
The Journal of Urology|July 1, 1993
Intraoperative ultrasound in the evaluation of tumor involvement of the inferior vena cavaJ P Long, P L Choyke, T A Shawker, et al.
Radiology|June 1, 1991
von Hippel-Lindau disease: inadequacy of angiography for identification of renal cancersD L Miller, P L Choyke, M M Walther, et al.
The Journal of Urology|February 25, 1998
Serum interleukin-6 levels in metastatic renal cell carcinoma before treatment with interleukin-2 correlates with paraneoplastic syndromes but not patient survivalM M Walther, B Johnson, D Culley, et al.
World Journal of Urology|January 1, 1996
Isolated perfusion of the kidney with tumor necrosis factor for localized renal-cell carcinomaM M Walther, S B Jennings, P L Choyke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1992
Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancerC Myers, M Cooper, C Stein, et al.
Journal of the National Cancer Institute|April 20, 2001
Radiofrequency ablation: a novel approach for treatment of metastatic pheochromocytomaK Pacak, T Fojo, D S Goldstein, et al.
Urology|September 1, 1993
Cytoreductive surgery prior to interleukin-2-based therapy in patients with metastatic renal cell carcinomaM M Walther, R B Alexander, G H Weiss, et al.
Pageof 12